| Sara Suzette Sinex, RNMSNCNS | |
|
831 Dillon Dr, Richmond, IN 47374-8048 | |
| (765) 983-8058 | |
| (765) 983-8609 |
| Full Name | Sara Suzette Sinex |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health |
| Location | 831 Dillon Dr, Richmond, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598091019 | NPI | - | NPPES |
| 70000046A | Other | IN | APN |
| 28078531A | Other | IN | RN |
| 70000046B | Other | IN | CSR PRESCRIPTIVE AUTHORITY |
| Mailing Address | Practice Location Address |
|---|---|
| Sara Suzette Sinex, RNMSNCNS 645 S Rogers St, Bloomington, IN 47403-2353 Ph: (812) 339-1691 | Sara Suzette Sinex, RNMSNCNS 831 Dillon Dr, Richmond, IN 47374-8048 Ph: (765) 983-8058 |
News Archive
A large population-based study of diabetes in China conducted by investigators from Tulane University and their colleagues in China has concluded that the disease has reached epidemic proportions in the adult population of China. The study estimates that 92.4 million adults age 20 or older (9.7 percent of the population) have diabetes and 148.2 million adults (15.5 percent) have prediabetes, a key risk factor for the development of overt diabetes and cardiovascular disease.
Predictive Biosciences today announced that it has acquired Cleveland, Ohio based OncoDiagnostic Laboratory ("ODL"), a private, Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians nationwide.
Researchers from the University of Utah have gained new insight into the regulation of adult nerve cell generation in the hypothalamus, the part of the brain that regulates many aspects of behavior, mood, and metabolism.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
› Verified 6 days ago
Gina Marie Robinson, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 400 Industries Rd, Richmond, IN 47374 Phone: 765-935-0135 Fax: 765-935-0150 | |
Jo Ann Bond, APRN, CNS-BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 980 Chester Blvd, Richmond, IN 47374 Phone: 765-983-3410 Fax: 765-983-3045 |